Argeris N. Karabelas

Insider Reports History

Entity
Individual
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Argeris N. Karabelas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bausch Health Companies Inc. Director Common Shares, No Par Value 124K $992K $8.02 Jun 24, 2022 Direct
REGENXBIO Inc. Director Common Stock 11.3K $114K $10.11 Oct 1, 2024 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 30K Jul 1, 2024 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 0 Oct 1, 2024 Direct

Insider Reports Filed by Argeris N. Karabelas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Oct 1, 2024 3 -$63.5K 4 Oct 2, 2024 Director
RGNX REGENXBIO Inc. Sep 3, 2024 4 -$78K 4 Sep 4, 2024 Director
RGNX REGENXBIO Inc. Aug 1, 2024 7 -$97.6K 4 Aug 5, 2024 Director
RGNX REGENXBIO Inc. Jul 29, 2024 3 -$25.4K 4 Jul 30, 2024 Director
RGNX REGENXBIO Inc. Jul 1, 2024 3 -$75.1K 4 Jul 3, 2024 Director
RGNX REGENXBIO Inc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
RGNX REGENXBIO Inc. Jun 2, 2023 2 $0 4 Jun 6, 2023 Director
BHC Bausch Health Companies Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
RGNX REGENXBIO Inc. Jun 3, 2022 2 $0 4 Jun 7, 2022 Director
RGNX REGENXBIO Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director